"Theranostic Nanomedicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An integrated nano-scale approach to MEDICINE which involves concurrent diagnosis, drug delivery, therapy, and monitoring of therapeutic response.
| Descriptor ID |
D000068936
|
| MeSH Number(s) |
E01.894 E02.921 H01.603.600.500 H02.403.845 J01.897.520.600.600.500
|
| Concept/Terms |
Theranostic Nanomedicine- Theranostic Nanomedicine
- Nanomedicine, Theranostic
- Nanomedicines, Theranostic
- Theranostic Nanomedicines
|
Below are MeSH descriptors whose meaning is more general than "Theranostic Nanomedicine".
Below are MeSH descriptors whose meaning is more specific than "Theranostic Nanomedicine".
This graph shows the total number of publications written about "Theranostic Nanomedicine" by people in this website by year, and whether "Theranostic Nanomedicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 2 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Theranostic Nanomedicine" by people in Profiles.
-
Theranostic nanoparticles for detection and treatment of pancreatic cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jul-Aug; 16(4):e1983.
-
Facile development of biodegradable polymer-based nanotheranostics: Hydrophobic photosensitizers delivery, fluorescence imaging and photodynamic therapy. J Photochem Photobiol B. 2019 Apr; 193:39-50.
-
Theranostic molecular profiling of pleomorphic ductal carcinoma of the breast. Breast J. 2019 01; 25(1):175-176.
-
Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Biomaterials. 2018 11; 182:114-126.
-
Exosomes as Theranostics for Lung Cancer. Adv Cancer Res. 2018; 139:1-33.
-
Apocrine carcinoma of the breast: A brief update on the molecular features and targetable biomarkers. Bosn J Basic Med Sci. 2017 Feb 21; 17(1):9-11.
-
Motion Compensated Ultrasound Imaging Allows Thermometry and Image Guided Drug Delivery Monitoring from Echogenic Liposomes. Theranostics. 2016; 6(11):1963-74.
-
Cell-Specific Promoters Enable Lipid-Based Nanoparticles to Deliver Genes to Specific Cells of the Retina In Vivo. Theranostics. 2016; 6(10):1514-27.
-
Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. J Control Release. 2016 06 10; 231:60-7.